1,571
Views
53
CrossRef citations to date
0
Altmetric
Reviews

Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials

, , , , , , , , & show all

References

  • Bábíčková, J., B. M. Klinkhammer, E. M. Buhl, S. Djudjaj, M. Hoss, F. Heymann, F. Tacke, J. Floege, J. U. Becker, and P. Boor. 2017. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney International 91 (1):70–85. doi: 10.1016/j.kint.2016.07.038.
  • Barreto, F. C., D. V. Barreto, S. Liabeuf, N. Meert, G. Glorieux, M. Temmar, G. Choukroun, R. Vanholder, and Z. A. Massy. 2009. Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clinical Journal of the American Society of Nephrology 4 (10):1551–8. doi: 10.2215/CJN.03980609.
  • Bergeron, N., P. T. Williams, R. Lamendella, N. Faghihnia, A. Grube, X. Li, Z. Wang, R. Knight, J. K. Jansson, S. L. Hazen, et al. 2016. Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk. British Journal of Nutrition 116 (12):2020–9. doi: 10.1017/S0007114516004165.
  • Beserra, B. T., R. Fernandes, V. A. do Rosario, M. C. Mocellin, M. G. Kuntz, and E. B. Trindade. 2015. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clinical Nutrition 34 (5):845–58. doi: 10.1016/j.clnu.2014.10.004.
  • Calderini, E., H. U. Celebioglu, J. Villarroel, S. Jacobsen, B. Svensson, and E. Pessione. 2017. Comparative proteomics of oxidative stress response of Lactobacillus acidophilus NCFM reveals effects on DNA repair and cysteine de novo synthesis. Proteomics 17 (5):1600178. doi: 10.1002/pmic.201600178.
  • Claesson, M. J., S. Cusack, O. O'Sullivan, R. Greene-Diniz, H. de Weerd, E. Flannery, J. R. Marchesi, D. Falush, T. Dinan, G. Fitzgerald, et al. 2011. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proceedings of the National Academy of Sciences of the United States of America 108 (Supplement_1):4586–91. doi: 10.1073/pnas.1000097107.
  • Duval, S., and R. Tweedie. 2000. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2):455–63. doi: 10.1111/j.0006-341X.2000.00455.x.
  • Esgalhado, M., J. A. Kemp, R. Azevedo, B. R. Paiva, M. B. Stockler-Pinto, C. J. Dolenga, N. A. Borges, L. S. Nakao, and D. Mafra. 2018. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial. Food & Function 9 (12):6508–16. doi: 10.1039/C8FO01876F.
  • Felizardo, R. J. F., I. K. M. Watanabe, P. Dardi, L. V. Rossoni, and N. O. S. Câmara. 2019. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids. Pharmacological Research 141:366–77. doi: 10.1016/j.phrs.2019.01.019.
  • Firouzi, S., and F. Haghighatdoost. 2018. The effects of prebiotic, probiotic, and synbiotic supplementation on blood parameters of renal function: A systematic review and meta-analysis of clinical trials. Nutrition 51–52:104–13. doi: 10.1016/j.nut.2018.01.007.
  • Gibson, G. R., R. Hutkins, M. E. Sanders, S. L. Prescott, R. A. Reimer, S. J. Salminen, K. Scott, C. Stanton, K. S. Swanson, P. D. Cani, et al. 2017. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology 14 (8):491–502. doi: 10.1038/nrgastro.2017.75.
  • Gibson, G. R., and M. B. Roberfroid. 1995. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. The Journal of Nutrition 125 (6):1401–12. doi: 10.1093/jn/125.6.1401.
  • Guida, B., M. Cataldi, A. Memoli, R. Trio, M. di Maro, L. Grumetto, I. Capuano, S. Federico, A. Pisani, and M. Sabbatini. 2017. Effect of a short-course treatment with synbiotics on plasma p-cresol concentration in kidney transplant recipients. Journal of the American College of Nutrition 36 (7):586–91. doi: 10.1080/07315724.2017.1334602.
  • Guo, Z., X. M. Liu, Q. X. Zhang, Z. Shen, F. W. Tian, H. Zhang, Z. H. Sun, H. P. Zhang, and W. Chen. 2011. Influence of consumption of probiotics on the plasma lipidprofile: A meta-analysis of randomised controlled trials. Nutrition, Metabolism & Cardiovascular Diseases 21 (11):844–50. doi: 10.1016/j.numecd.2011.04.008.
  • Hadi, A., H. Mohammadi, M. Miraghajani, and E. Ghaedi. 2019. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. Critical Reviews in Food Science and Nutrition 59 (15):2494–505. doi: 10.1080/10408398.2018.1458021.
  • Haghighat, N., M. Mohammadshahi, S. Shayanpour, and M. H. Haghighizadeh. 2019. Effects of synbiotics and probiotics supplementation on serum levels of endotoxin, heat shock protein 70 antibodies and inflammatory markers in hemodialysis patients: A randomized double-blinded controlled trial. Probiotics and Antimicrobial Proteins 12 (1):144–51. doi: 10.1007/s12602-018-9509-5.
  • Hendijani, F., and V. Akbari. 2018. Probiotic supplementation for management of cardiovascular risk factors in adults with type II diabetes: A systematic review and meta-analysis. Clinical Nutrition 37 (2):532–41. doi: 10.1016/j.clnu.2017.02.015.
  • Heshmati, J., F. Farsi, F. Shokri, M. Rezaeinejad, A. Almasi-Hashiani, S. Vesali, and M. Sepidarkish. 2018. A systematic review and meta-analysis of the probiotics and synbiotics effects on oxidative stress. Journal of Functional Foods46:66–84. doi: 10.1016/j.jff.2018.04.049.
  • Higgins, J. P. T., R. Churchill, J. Chandler, and M. S. Cumpston, eds. 2017. Cochrane handbook for systematic reviews of interventions version 5.2.0. London, UK: The Cochrane Collaboration. www.training.cochrane.org/handbook.
  • Hill, C., F. Guarner, G. Reid, G. R. Gibson, D. J. Merenstein, B. Pot, L. Morelli, R. B. Canani, H. J. Flint, S. Salminen, et al. 2014. Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11 (8):506–14. doi: 10.1038/nrgastro.2014.66.
  • Kazemi, A., S. Soltani, S. Ghorabi, A. Keshtkar, E. Daneshzad, F. Nasri, and S. M. Mazloomi. 2020. Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials. Clinical Nutrition 39 (3):789–819. doi: 10.1016/j.clnu.2019.04.004.
  • Knauf, F., J. R. Brewer, and R. A. Flavell. 2019. Immunity, microbiota and kidney disease. Nature Reviews Nephrology 15 (5):263–74. doi: 10.1038/s41581-019-0118-7.
  • Kooshki, A., T. Tofighiyan, and M. Miri. 2019. A synbiotic supplement for inflammation and oxidative stress and lipid abnormalities in hemodialysis patients. Hemodialysis International 23 (2):254–60. doi: 10.1111/hdi.12748.
  • Koppe, L., D. Mafra, and D. Fouque. 2015. Probiotics and chronic kidney disease. Kidney International 88 (5):958–66. doi: 10.1038/ki.2015.255.
  • Liberati, A., D. G. Altman, J. Tetzlaff, C. Mulrow, P. C. Gøtzsche, J. P. Ioannidis, M. Clarke, P. J. Devereaux, J. Kleijnen, and D. Moher. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 339 (1):b2700. doi: 10.1136/bmj.b2700.
  • Lopes, R. C. S. O., K. P. Balbino, M. P. Jorge, A. Q. Ribeiro, H. S. D. Martino, and R. C. G. Alfenas. 2018. Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease: A systematic review. Nutrición Hospitalaria 35 (3):722–30. doi: 10.20960/nh.1642.
  • Mafi, A., G. Namazi, A. Soleimani, F. Bahmani, E. Aghadavod, and Z. Asemi. 2018. Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial. Food & Function 9 (9):4763–70. doi: 10.1039/C8FO00888D.
  • Mafra, D., N. Borges, L. Alvarenga, M. Esgalhado, L. Cardozo, B. Lindholm, and P. Stenvinkel. 2019. Dietary components that may influence the disturbed gut microbiota in chronic kidney disease. Nutrients 11 (3):496. doi: 10.3390/nu11030496.
  • March, D. S., A. W. Jones, N. C. Bishop, and J. O. Burton. 2019. The efficacy of prebiotic, probiotic, and synbiotic supplementation in modulating gut-derived circulatory particles associated with cardiovascular disease in individuals receiving dialysis: A systematic review and meta-analysis of randomized controlled trials. Journal of Renal Nutrition pii: S1051-2276(19)30292-4. doi: 10.1053/j.jrn.2019.07.006.
  • Mazidi, M., P. Rezaie, G. A. Ferns, and H. Vatanparast. 2017. Impact of probiotic administration on serum C-reactive protein concentrations: Systematic review and meta-analysis of randomized control trials. Nutrients 9 (1):20. doi: 10.3390/nu9010020.
  • Mazruei Arani, N., Z. Emam-Djomeh, H. Tavakolipour, R. Sharafati-Chaleshtori, A. Soleimani, and Z. Asemi. 2019. The effects of probiotic honey consumption on metabolic status in patients with diabetic nephropathy: A randomized, double-blind, controlled trial. Probiotics and Antimicrobial Proteins 11 (4):1195–201. doi: 10.1007/s12602-018-9468-x.
  • McFarlane, C., C. I. Ramos, D. W. Johnson, and K. L. Campbell. 2019. Prebiotic, probiotic, and synbiotic supplementation in chronic kidney disease: A systematic review and meta-analysis. Journal of Renal Nutrition 29 (3):209–20. doi: 10.1053/j.jrn.2018.08.008.
  • Meijers, B. K., V. De Preter, K. Verbeke, Y. Vanrenterghem, and P. Evenepoel. 2010. p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrology Dialysis Transplantation 25 (1):219–24. doi: 10.1093/ndt/gfp414.
  • Meijers, B., P. Evenepoel, and H. J. Anders. 2019. Intestinal microbiome and fitness in kidney disease. Nature Reviews Nephrology 15 (9):531–45. doi: 10.1038/s41581-019-0172-1.
  • Meng, X. M., D. J. Nikolic-Paterson, and H. Y. Lan. 2014. Inflammatory processes in renal fibrosis. Nature Reviews Nephrology 10 (9):493–503. doi: 10.1038/nrneph.2014.114.
  • Miraghajani, M., N. Zaghian, M. Mirlohi, A. Feizi, and R. Ghiasvand. 2017. The impact of probiotic soy milk consumption on oxidative stress among type 2 diabetic kidney disease patients: A randomized controlled clinical trial. Journal of Renal Nutrition 27 (5):317–24. doi: 10.1053/j.jrn.2017.04.004.
  • Pereira, D. I., and G. R. Gibson. 2002. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Critical Reviews in Biochemistry and Molecular Biology 37 (4):259–81. doi: 10.1080/10409230290771519.
  • Pisano, A., G. D’Arrigo, G. Coppolino, and D. Bolignano. 2018. Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis. Nutrients 10 (9):1224. doi: 10.3390/nu10091224.
  • Pontremoli, R., V. Bellizzi, S. Bianchi, R. Bigazzi, V. Cernaro, L. Del Vecchio, L. De Nicola, G. Leoncini, F. Mallamaci, C. Zoccali, et al. 2020. Management of dyslipidaemia in patients with chronic kidney disease: A position paper endorsed by the Italian Society of Nephrology. Journal of Nephrology. doi: 10.1007/s40620-020-00707-2.
  • Ramezani, A., Z. A. Massy, B. Meijers, P. Evenepoel, R. Vanholder, and D. S. Raj. 2016. Role of the gut microbiome in uremia: A potential therapeutic target. American Journal of Kidney Diseases 67 (3):483–98. doi: 10.1053/j.ajkd.2015.09.027.
  • Rodriguez, J., S. Hiel, A. M. Neyrinck, T. Le Roy, S. A. Pötgens, Q. Leyrolle, B. D. Pachikian, M. A. Gianfrancesco, P. D. Cani, N. Paquot, et al. 2020. Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients. Gut. doi: 10.1136/gutjnl-2019-319726.
  • Roshan, H., E. Ghaedi, J. Rahmani, M. Barati, M. Najafi, M. Karimzedeh, and O. Nikpayam. 2019. Effects of probiotics and synbiotic supplementation on antioxidant status: A meta-analysis of randomized clinical trials. Clinical Nutrition ESPEN 30:81–8. doi: 10.1016/j.clnesp.2019.02.003.
  • Rossi, M., D. W. Johnson, M. Morrison, E. M. Pascoe, J. S. Coombes, J. M. Forbes, C. C. Szeto, B. C. McWhinney, J. P. Ungerer, and K. L. Campbell. 2016. Synbiotics easing renal failure by improving gut microbiology (SYNERGY): A randomized trial. Clinical Journal of the American Society of Nephrology 11 (2):223–31. doi: 10.2215/CJN.05240515.
  • Rossi, M., K. Klein, D. W. Johnson, and K. L. Campbell. 2012. Pre-, pro-, and synbiotics: Do they have a role in reducing uremic toxins? A systematic review and meta-analysis. International Journal of Nephrology 2012:1–20. doi: 10.1155/2012/673631.
  • Schünemann, H. J., A. D. Oxman, J. Brozek, P. Glasziou, R. Jaeschke, G. E. Vist, J. W. Williams, Jr., R. Kunz, J. Craig, V. M. Montori, P. Bossuyt, et al. 2008. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 336 (7653):1106–10. doi: 10.1136/bmj.39500.677199.AE.
  • Segain, J. P., D. Raingeard de la Blétière, A. Bourreille, V. Leray, N. Gervois, C. Rosales, L. Ferrier, C. Bonnet, H. M. Blottière, and J. P. Galmiche. 2000. Butyrate inhibits inflammatory responses through NFkappaB inhibition: Implications for Crohn’s disease. Gut 7 (3):397–403. doi: 10.1136/gut.47.3.397.
  • Shariaty, Z., G. R. Mahmoodi Shan, M. Farajollahi, M. Amerian, and N. Behnam Pour. 2017. The effects of probiotic supplement on hemoglobin in chronic renal failure patients under hemodialysis: A randomized clinical trial. Journal of Research in Medical Sciences 21 (22):74. doi: 10.4103/jrms.JRMS_614_16.
  • Shimizu, M., M. Hashiguchi, T. Shiga, H. O. Tamura, and M. Mochizuki. 2015. Meta-analysis: Effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolemic individuals. PLoS One 10 (10):e0139795. doi: 10.1371/journal.pone.0139795.
  • Shinde, T., A. P. Perera, R. Vemuri, S. V. Gondalia, A. V. Karpe, D. J. Beale, S. Shastri, B. Southam, R. Eri, and R. Stanley. 2019. Synbiotic supplementation containing whole plant sugar cane fibre and probiotic spores potentiates protective synergistic effects in mouse model of IBD. Nutrients 11 (4):818. doi: 10.3390/nu11040818.
  • Sirich, T. L., N. S. Plummer, C. D. Gardner, T. H. Hostetter, and T. W. Meyer. 2014. Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients. Clinical Journal of the American Society of Nephrology 9 (9):1603–10. doi: 10.2215/CJN.00490114.
  • Snelson, M., N. J. Kellow, and M. T. Coughlan. 2019. Modulation of the gut microbiota by resistant starch as a treatment of chronic kidney diseases: Evidence of efficacy and mechanistic insights. Advances in Nutrition 10 (2):303–20. doi: 10.1093/advances/nmy068.
  • Soleimani, A., M. Zarrati Mojarrad, F. Bahmani, M. Taghizadeh, M. Ramezani, M. Tajabadi-Ebrahimi, P. Jafari, A. Esmaillzadeh, and Z. Asemi. 2017. Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney International 91 (2):435–42. doi: 10.1016/j.kint.2016.09.040.
  • Tao, S., S. Tao, Y. Cheng, J. Liu, L. Ma, and P. Fu. 2019. Effects of probiotic supplements on the progression of chronic kidney disease: A meta-analysis. Nephrology (Carlton) 24 (11):1122–30. doi: 10.1111/nep.13549.
  • Thomas, B., K. Matsushita, K. H. Abate, Z. Al-Aly, J. Ärnlöv, K. Asayama, R. Atkins, A. Badawi, S. H. Ballew, A. Banerjee, et al. 2017. Global cardiovascular and renal outcomes of reduced GFR. Journal of the American Society of Nephrology 28 (7):2167–79. doi: 10.1681/ASN.2016050562.
  • Thongprayoon, C., W. Kaewput, S. T. Hatch, T. Bathini, K. Sharma, K. Wijarnpreecha, P. Ungprasert, M. D’Costa, M. A. Mao, and W. Cheungpasitporn. 2019. Effects of probiotics on inflammation and uremic toxins among patients on dialysis: A systematic review and meta-analysis. Digestive Diseases and Sciences 64 (2):469–79. doi: 10.1007/s10620-018-5243-9.
  • Ursell, L. K., H. J. Haiser, W. Van Treuren, N. Garg, L. Reddivari, J. Vanamala, P. C. Dorrestein, P. J. Turnbaugh, and R. Knight. 2014. The intestinal metabolome: An intersection between microbiota and host. Gastroenterology 146 (6):1470–6. doi: 10.1053/j.gastro.2014.03.001.
  • Vaziri, N. D. 2016. Effect of synbiotic therapy on gut–derived uremic toxins and the intestinal microbiome in patients with CKD. Clinical Journal of the American Society of Nephrology 11 (2):199–201. doi: 10.2215/CJN.13631215.
  • Vaziri, N. D., S. M. Liu, W. L. Lau, M. Khazaeli, S. Nazertehrani, S. H. Farzaneh, D. A. Kieffer, S. H. Adams, and R. J. Martin. 2014. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLoS One 9 (12):e114881. doi: 10.1371/journal.pone.0114881.
  • Vaziri, N. D., J. Wong, M. Pahl, Y. M. Piceno, J. Yuan, T. Z. DeSantis, Z. Ni, T. H. Nguyen, and G. L. Andersen. 2013. Chronic kidney disease alters intestinal microbial flora. Kidney International 83 (2):308–15. doi: 10.1038/ki.2012.345.
  • Viramontes-Hörner, D., F. Márquez-Sandoval, F. Martín-del-Campo, B. Vizmanos-Lamotte, A. Sandoval-Rodríguez, J. Armendáriz-Borunda, H. García-Bejarano, K. Renoirte-López, and G. García-García. 2015. Effect of a symbiotic gel (Lactobacillus acidophilus + Bifidobacterium lactis + inulin) on presence and severity of gastrointestinal symptoms in hemodialysis patients. Journal of Renal Nutrition 25 (3):284–91. doi: 10.1053/j.jrn.2014.09.008.
  • Walther, C. P., and K. F. Erickson. 2019. The cost-effectiveness of lipid lowering for primary cardiovascular prevention in chronic kidney disease: Moving beyond statins. Kidney International 96 (1):22–5. doi: 10.1016/j.kint.2019.02.029.
  • Wang, Z., E. Klipfell, B. J. Bennett, R. Koeth, B. S. Levison, B. Dugar, A. E. Feldstein, E. B. Britt, X. Fu, Y. M. Chung, et al. 2011. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (7341):57–63. doi: 10.1038/nature09922.
  • Wang, Y., Y. Wu, Y. Wang, H. Xu, X. Mei, D. Yu, Y. Wang, and W. Li. 2017. Antioxidant properties of probiotic bacteria. Nutrients 9 (5):521. doi: 10.3390/nu9050521.
  • Wong, J., Y. M. Piceno, T. Z. Desantis, M. Pahl, G. L. Andersen, and N. D. Vaziri. 2014. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. American Journal of Nephrology 39 (3):230–7. doi: 10.1159/000360010.
  • Wu, Y., L. A. Potempa, D. El Kebir, and J. G. Filep. 2015. C-reactive protein and inflammation: Conformational changes affect function. Biological Chemistry 396 (11):1181–97. doi: 10.1515/hsz-2015-0149.
  • Wu, Y., Q. Zhang, Y. Ren, and Z. Ruan. 2017. Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials. PLoS One 12 (6):e0178868. doi: 10.1371/journal.pone.0178868.
  • Xie, L. M., Y. Y. Ge, X. Huang, Y. Q. Zhang, and J. X. Li. 2015. Effects of fermentable dietary fiber supplementation on oxidative and inflammatory status in hemodialysis patients. International Journal of Clinical and Experimental Medicine 8 (1):1363–9. PMID: 25785138.
  • Yang, T., E. M. Richards, C. J. Pepine, and M. K. Raizada. 2018. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease. Nature Reviews Nephrology 14 (7):442–56. doi: 10.1038/s41581-018-0018-2.
  • Zamani, B., A. Sheikhi, N. Namazi, B. Larijani, and L. Azadbakht. 2019. The effects of supplementation with probiotic on biomarkers of oxidative stress in adult subjects: A systematic review and meta-analysis of randomized trials. Probiotics and Antimicrobial Proteins 12 (1):102–11. doi: 10.1007/s12602-018-9500-1.
  • Zhou, J., R. J. Martin, R. T. Tulley, A. M. Raggio, K. L. McCutcheon, L. Shen, S. C. Danna, S. Tripathy, M. Hegsted, and M. J. Keenan. 2008. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. American Journal of Physiology: Endocrinology and Metabolism 295 (5):1160–6. doi: 10.1152/ajpendo.90637.2008.
  • Zybailov, B. L., G. V. Glazko, Y. Rahmatallah, D. S. Andreyev, T. McElroy, O. Karaduta, S. D. Byrum, L. Orr, A. J. Tackett, S. G. Mackintosh, et al. 2019. Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats. PLoS One 14 (1):e0199274. doi: 10.1371/journal.pone.0199274.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.